Sugi Predict

Sugi Predict / Compounds / SCHEMBL3754584

SCHEMBL3754584

SCHEMBL3754584

CCC(=O)OC1c2ccccc2-c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.50
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ CYP1A2 P05177 4/20 0.41
▸ MAPT P10636 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ NCOR2 Q9Y618 1/20 0.39
▸ TSHR P16473 3/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27864062 0.86 POLB (0.47) POLBBCHEACHEKMT2ACYP1A2
SCHEMBL27555134 0.85 POLB (0.48) POLBBCHEACHEKMT2ACYP1A2
SCHEMBL27878603 0.82 BCHE (0.49) POLBBCHEACHEKMT2AGAA
SCHEMBL21778843 0.81 POLB (0.46) POLBBCHEACHEKMT2ACYP1A2
SCHEMBL27593730 0.81 POLB (0.46) POLBBCHEACHEKMT2ACYP1A2
SCHEMBL29142881 0.81 POLB (0.46) POLBBCHEACHEKMT2ACYP1A2
SCHEMBL23158452 0.81 ACP3 (0.46) CYP3A4CYP2D6
SCHEMBL27984068 0.80 BCHE (0.47) POLBBCHEACHE
SCHEMBL28476456 0.80 BCHE (0.47) POLBBCHEACHE
SCHEMBL9379518 0.79 BCHE (0.43) POLBBCHEACHEKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612097-B Liposome drug delivery vehicle 耶达研究及发展有限公司 2023-10-20 — — CN disclosed
CN-109233810-B Chromophoric polymer dots 华盛顿大学商业化中心 2022-05-03 — — CN disclosed
CN-111769285-B Lithium battery negative electrode adhesive and negative electrode plate 苏州凌威新能源科技有限公司 2022-04-01 — — CN disclosed
CN-111769285-A Lithium battery negative electrode adhesive and negative electrode plate 苏州凌威新能源科技有限公司 2020-10-13 — — CN disclosed
CN-111116576-A Quinolizinone compound and preparation method thereof 北京师范大学 2020-05-08 — — CN disclosed
CN-110612097-A Liposomal drug delivery vehicles 耶达研究及发展有限公司 2019-12-24 — — CN disclosed
US-20190187342-A1 ANTIREFLECTIVE FILM, METHOD OF PRODUCING ANTIREFLECTIVE FILM, AND EYEGLASS TYPE DISPLAY SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-06-20 — — US disclosed
US-9422229-B2 Therapeutic compounds UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-08-23 — — US disclosed
EP-2164324-B1 THERAPEUTIC COMPOUNDS UNIV FLORIDA (US) 2014-08-13 — — EP disclosed
US-20140155490-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-06-05 — — US disclosed
CN-103261087-A Chromophoric polymer dots UNIV WASHINGTON CT COMMERCIALIZATION 2013-08-21 — — CN disclosed
US-8242154-B2 Compounds, compositions and methods of using same for modulating uric acid levels ARDEA BIOSCIENCES, INC. (US) 2012-08-14 — — US disclosed
US-8211898-B2 Substituted thieno[3,2-d]pyrimidines as HIV inhibitors ARDEA BIOSCIENCES, INC. (US) 2012-07-03 — — US disclosed
US-8173690-B2 Compounds, compositions and methods of using same for modulating uric acid levels ARDEA BIOSCIENCES, INC. (US) 2012-05-08 — — US disclosed
CN-102285881-A Precursor compound of dichloroacetate and preparation method thereof — 2011-12-21 — — CN disclosed
US-20100305212-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-12-02 — — US disclosed
US-20100056464-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USING SAME FOR MODULATING URIC ACID LEVELS ARDEA BIOSCIENCES (US) 2010-03-04 — — US disclosed
US-20100056465-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USING SAME FOR MODULATING URIC ACID LEVELS ARDEA BIOSCIENCES (US) 2010-03-04 — — US disclosed
US-20090281124-A1 4-CYANOPHENYLAMINO-SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INHIBITORS ARDEA BIOSCIENCES (US) 2009-11-12 — — US disclosed
CN-1327383-A Pharmaceutical for treatment of neurological and neuropsychiatric disorders ALERICS NEUROSCIENCE CO (US) 2001-12-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056465-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USING SAME FOR MODULATING URIC ACID LEVELS XDH, PON1, OAT POLB 2505/4885BCHE 1372/4885ACHE 591/4885
US-20140155490-A1 THERAPEUTIC COMPOUNDS HTR2C, HTR3B, HTR2A POLB 4642/4885BCHE 3530/4885ACHE 2876/4885
US-20090281124-A1 4-CYANOPHENYLAMINO-SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INHIBITORS CYCS, DCK, NSUN2 POLB 60/4885BCHE 827/4885ACHE 4048/4885
US-20100056464-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USING SAME FOR MODULATING URIC ACID LEVELS XDH, PON1, OAT POLB 2505/4885BCHE 1372/4885ACHE 591/4885
US-20100305212-A1 THERAPEUTIC COMPOUNDS HTR2C, HTR3B, HTR2A POLB 4642/4885BCHE 3530/4885ACHE 2876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.